Active Ingredient: PIMAVANSERIN TARTRATE
Proprietary Name: NUPLAZID
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 34MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N210793
Product Number: 001
Approval Date: Jun 28, 2018
Applicant Holder Full Name: ACADIA PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
